{"id":60739,"name":"BIONTECH US INC.","slug":"biontech-us-inc","state":"MA","country":"United States of America","description":"Immunotherapy research and development","totalSpending":660000,"filings":8,"yearlySpending":[{"year":2024,"income":290000},{"year":2025,"income":370000}],"issues":["MED","HCR","GOV"],"firms":["CORNERSTONE GOVERNMENT AFFAIRS, INC."],"lobbyists":["WENDY SAMMONS-JACKSON","ANTHONY LAZARSKI","SUSAN SWEAT","MICHAEL SMITH","DAO NGUYEN","STACY RICH","DAVID PLANNING"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues impacting development of immunotherapies and optimizing use of mRNA technology.","Issues impacting development of immunotherapies and optimizing use of mRNA technology.","Educated policymakers on BioNTech's federally funded research and development activities.","Educated policymakers on BioNTech's federally funded research and development activities.","Educated policymakers on BioNTech's federally funded research and development activities."],"years":[2024,2025]}